Seer Investor Relations Material
Latest events
Q1 2025
Seer
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seer Inc
Access all reports
Seer Inc develops life sciences technologies intended to enable discovery of proteomic biomarkers with high throughput and precision. The company’s products support research in areas such as biomarker identification, disease detection, and therapeutic development. Seer serves pharmaceutical, academic, and research institutions in the life sciences sector. The company is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.
Key slides for Seer Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Seer Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Seer Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
SEER
Country
🇺🇸 United States